These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7879226)

  • 1. Does suboptimal immunosuppression contribute to chronic rejection?
    Simić S; Djukanović L; Stojković D; Balgojević R; Sinthoić M; Lezaić V; Radivojević D
    Transplant Proc; 1995 Feb; 27(1):909-10. PubMed ID: 7879226
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic rejection in 500 kidney transplant patients treated with cyclosporine: incidence and risk factors.
    Pallardó LM; Sánchez J; Puig N; Sánchez P; Beneyto I; Crespo J; Ros F; Rochera A
    Transplant Proc; 1995 Aug; 27(4):2215-6. PubMed ID: 7652778
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of the risk factors of late failure in renal transplantation under cyclosporine immunosuppression.
    Pallardó LM; Sánchez P; Sánchez J; García J; Beneyto I; Orero E; Rochera A
    Transplant Proc; 1994 Oct; 26(5):2536-7. PubMed ID: 7940781
    [No Abstract]   [Full Text] [Related]  

  • 4. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A; Sells RA; Bakran A; Tewari A
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract]   [Full Text] [Related]  

  • 5. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimum maintenance dosage of cyclosporine and the impact on the occurrence of chronic rejection: an extensive multivariate analysis.
    Sumethkul V; Jirasiritham S; Chiewsilp P
    Transplant Proc; 1995 Feb; 27(1):844-5. PubMed ID: 7879201
    [No Abstract]   [Full Text] [Related]  

  • 7. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
    Brayman KL; Egidi MF; Naji A; Friedman AL; Holland MT; Tomaszewski JE; Samini F; Perloff J; Grossman R; Barker CF
    Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine levels predict the likelihood of rejection after simultaneous pancreas/kidney transplantation.
    Dawidson I; Lu C; Ar'Rajab A; Rossi P; Melone D; Wheeler D
    Transplant Proc; 1994 Apr; 26(2):534. PubMed ID: 8171540
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine improves results in HLA-identical sibling renal transplants.
    Van Buren D; MacDonell R; Johnson HK; Richie R; Ynares C; Helderman JH; Green W; Crowe D
    Transplant Proc; 1994 Oct; 26(5):2514-5. PubMed ID: 7940772
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine monotherapy in children: long-term effect.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Oct; 26(5):2610-6. PubMed ID: 7940813
    [No Abstract]   [Full Text] [Related]  

  • 11. Ten years' experience with cyclosporine monotherapy after renal transplantation.
    Hillebrand G; Schneeberger H; Schleibner S; Krumme D; Hillebrand C; Burkhardt K; Hacker H; Illner WD; Land W
    Transplant Proc; 1993 Feb; 25(1 Pt 1):513-4. PubMed ID: 8438395
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction therapy with cyclosporine and without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
    Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK
    Transplant Proc; 1994 Oct; 26(5):2749. PubMed ID: 7940864
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine levels impact early rejection episodes.
    Granger DK; Amin NB; Sorenson AL; Gillingham KJ; Canafax DM; Matas AJ
    Transplant Proc; 1994 Oct; 26(5):2513. PubMed ID: 7940771
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytokine-release syndrome: differences between high and low doses of OKT3.
    Norman DJ; Kimball JA; Barry JM
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):35-8. PubMed ID: 8465420
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of cyclosporine dose on long-term outcome after heart transplantation.
    Valantine H; Hunt S; Gamberg P; Miller J; Luikart H
    Transplant Proc; 1994 Oct; 26(5):2710-2. PubMed ID: 7940848
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimization of cyclosporine monotherapy--long-term graft function.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Oct; 26(5):2501-6. PubMed ID: 7940767
    [No Abstract]   [Full Text] [Related]  

  • 17. Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation.
    Ketel BL; Turton-Weeks S; Reed K; Barone GW
    Transplant Proc; 1996 Apr; 28(2):899. PubMed ID: 8623453
    [No Abstract]   [Full Text] [Related]  

  • 18. Short- and long-term cyclosporine dosage in liver transplantation.
    McCaughan GW; Bookallil MJ; Sheil AG
    Transplant Proc; 1994 Oct; 26(5):2674-5. PubMed ID: 7940837
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal transplantation in older patients with double therapy with optional change to cyclosporine monotherapy: long-term results.
    Morales JM; Muñoz MA; Campo C; Andres A; Araque A; Alamo C; Praga M; Ortuño T; Hernandez E; Rodicio JL
    Transplant Proc; 1994 Oct; 26(5):2511-2. PubMed ID: 7940770
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumors after transplantation: are there associated factors?
    Jacobs U; Paar D; Buszello H; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3248. PubMed ID: 8962258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.